Direct antiviral agent treatment of decompensated hepatitis C virus-induced liver cirrhosis

par Ohkoshi, Shogo, Hirono, Haruka, Yamagiwa, Satoshi
Publié dans World J Gastrointest Pharmacol Ther (2015)

Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance

par Yamagiwa, Satoshi, Kamimura, Hiroteru, Takamura, Masaaki, Aoyagi, Yutaka
Publié 2014

Stomach Dysfunction Is a Potential Risk Factor for Wernicke's Encephalopathy

par Nakano, Oki, Tsuchiya, Atsunori, Yamagiwa, Satoshi, Terai, Shuji
Publié dans Intern Med (2016)

Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae

par Setsu, Toru, Tsuchiya, Atsunori, Yamagiwa, Satoshi, Terai, Shuji
Publié dans Intern Med (2017)

Diversion colitis and pouchitis: A mini-review

par Tominaga, Kentaro, Kamimura, Kenya, Takahashi, Kazuya, Yokoyama, Junji, Yamagiwa, Satoshi, Terai, Shuji
Publié dans World J Gastroenterol (2018)

Presence of Antibodies against Self Human Leukocyte Antigen Class II Molecules in Autoimmune Hepatitis

par Yamagiwa, Satoshi, Kamimura, Hiroteru, Takamura, Masaaki, Genda, Takuya, Ichida, Takafumi, Nomoto, Minoru, Aoyagi, Yutaka
Publié 2014

Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention

par Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Aoki, Yo-hei, Matsuda, Yasunobu, Aoyagi, Yutaka
Publié 2010

Spontaneous regression of hepatocellular carcinoma: A mini-review

par Sakamaki, Akira, Kamimura, Kenya, Abe, Satoshi, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Yamagiwa, Satoshi, Terai, Shuji
Publié dans World J Gastroenterol (2017)

Different distribution of mucosal-associated invariant T cells within the human cecum and colon

par Hama, Isamu, Tominaga, Kentaro, Yamagiwa, Satoshi, Setsu, Toru, Kimura, Naruhiro, Kamimura, Hiroteru, Wakai, Toshifumi, Terai, Shuji
Publié dans Cent Eur J Immunol (2019)

DNA Damage Sensor γ-H2AX Is Increased in Preneoplastic Lesions of Hepatocellular Carcinoma

par Matsuda, Yasunobu, Wakai, Toshifumi, Kubota, Masayuki, Osawa, Mami, Takamura, Masaaki, Yamagiwa, Satoshi, Aoyagi, Yutaka, Sanpei, Ayumi, Fujimaki, Shun
Publié 2013

A Mesenteric Desmoid Tumor with Rapid Progression

par Hayashi, Kazunao, Takamura, Masaaki, Yokoyama, Hisashi, Sato, Yuichi, Yamagiwa, Satoshi, Nogami, Hitoshi, Wakai, Toshifumi, Hasegawa, Go, Terai, Shuji
Publié dans Intern Med (2017)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient

par Sakamaki, Akira, Watanabe, Takayuki, Abe, Satoshi, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Yamagiwa, Satoshi, Terai, Shuji
Publié dans Clin J Gastroenterol (2017)

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C

par Yamagiwa, Satoshi, Ishikawa, Toru, Waguri, Nobuo, Sugitani, Soichi, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Terai, Shuji
Publié dans Int J Med Sci (2017)

Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein

par Setsu, Toru, Tsuchiya, Atsunori, Watanabe, Takayuki, Nagoya, Takuro, Ikarashi, Satoshi, Hayashi, Kazunao, Yokoyama, Junji, Yamagiwa, Satoshi, Terai, Shuji
Publié dans Case Rep Gastroenterol (2017)

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

par Kamimura, Kenya, Suda, Takeshi, Tamura, Yasushi, Takamura, Masaaki, Yokoo, Takeshi, Igarashi, Masato, Kawai, Hirokazu, Yamagiwa, Satoshi, Nomoto, Minoru, Aoyagi, Yutaka
Publié 2012

A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma

par Osaki, Akihiko, Suda, Takeshi, Kamimura, Kenya, Tsuchiya, Atsunori, Tamura, Yasushi, Takamura, Masaaki, Igarashi, Masato, Kawai, Hirokazu, Yamagiwa, Satoshi, Aoyagi, Yutaka
Publié 2013

Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C

par Yamagiwa, Satoshi, Ishikawa, Toru, Waguri, Nobuo, Sugitani, Soichi, Wakabayashi, Hiroto, Ohkoshi, Shogo, Tsukishiro, Takashi, Takahashi, Toru, Watanabe, Toshiaki, Terai, Shuji
Publié dans World J Hepatol (2017)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses

par Kamimura, Kenya, Yokoo, Takeshi, Kamimura, Hiroteru, Sakamaki, Akira, Abe, Satoshi, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Yamagiwa, Satoshi, Terai, Shuji
Publié dans PLoS One (2017)

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C

par Kamimura, Hiroteru, Yamagiwa, Satoshi, Tomohiro, Iwasaki, Higuchi, Wataru, Ogata, Norio, Tsuchiya, Atsunori, Kamimura, Kenya, Takamura, Masaaki, Kawai, Hirokazu, Terai, Shuji
Publié dans Am J Case Rep (2018)

Renal Impairment in Chronic Hepatitis B: A Review

par Kamimura, Hiroteru, Setsu, Toru, Kimura, Naruhiro, Yokoo, Takeshi, Sakamaki, Akira, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Yamagiwa, Satoshi, Terai, Shuji
Publié dans Diseases (2018)